Drug intelligence / Profile preview

zerumbone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal (investigational/preclinical), Topical (rare, Plant Extract Formulations)
01

Overview

**Zerumbone** is a natural monocyclic sesquiterpene (phytochemical cyclic ketone) primarily isolated from the rhizomes of *Zingiber zerumbet* (a ginger of the Zingiberaceae family)[2][7]. It displays a broad spectrum of biological activities: antitumor (via selective apoptosis of various cancer cell lines by upregulating TRAIL death receptors DR4/DR5 and downregulating cFLIP), antioxidant, anti-inflammatory (inhibiting lipocalin-2, production of reactive oxygen species, cytokines such as IL-6, IL-1β, TNF-α), antimicrobial, anti-nociceptive, immunomodulatory, anti-diabetic, anti-hyperlipidemic, hepatoprotective, gastroprotective, and anti-proliferative effects[1][2][3][4][7][8]. Zerumbone acts on multiple molecular pathways including NF-κB inhibition, reactive oxygen species mediation, modulation of p53, Bax, and p21, with some efficacy in preclinical models of learning/memory impairment and neuroinflammation[1][2][3]. It is highly lipophilic, with poor aqueous solubility and limited oral bioavailability, and is mostly researched for its potential as a dietary supplement and investigational drug for chronic inflammatory, neoplastic, and neurodegenerative diseases[2][6][7].

Other names
(2E,6E,10E)-2,6,9,9-tetramethylcycloundeca-2,6,10-trien-1-oneshampoo ginger compoundZER
02

Targets

CFLAR (CASP8 and FADD-like apoptosis regulator)CNR1 (Cannabinoid receptor 1)PPARA (Peroxisome proliferator-activated receptor alpha)TNFRSF10A (Death receptor 4)PPARG (Peroxisome proliferator-activated receptor gamma)TNFRSF10B (DR5)

Beyond the preview

Go deeper on zerumbone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zerumbone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call